Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • 29 - Bang for the buck: what purchasers and commissioners think and do

  • from SECTION 8 - FERTILITY TREATMENT: SCIENCE AND REALITY – THE NHS AND THE MARKET
    • By Berkeley Greenwood, National Infertility Awareness Campaign (NIAC) and Portcullis Public Affairs
  • Edited by Susan Bewley, William Ledger, University of New South Wales, Sydney, Dimitrios Nikolaou
  • Book:
    Reproductive Ageing
    Published online:
    05 February 2014
    Print publication:
    01 June 2009, pp 303-312

  • Summary

    Science has developed on from the now relatively basic and clumsy process of in vitro fertilisation (IVF) simply mixing gametes together outside the body and re-implanting them. When National Institute for Health and Clinical Excellence (NICE) examined the question of infertility, it used a fairly basic estimate of cost effectiveness related to the numbers of cycles performed and their cost and likely success rates in various age bands. Criteria with regard to secondary infertility inadvertently discriminate against older people, since these are more likely to be in second or third relationships. Denying a couple the chance of treatment if there is a pre-existing child from any previous relationship seems especially harsh but is frequently applied. Good evidence exists on the Human Fertilisation and Embryology Authority (HFEA) database as to the value of the treatment, and success rates have continued to rise over the past 10 years.